Risperidone long-acting injection (RLAI): The 12-week efficacy and tolerability in thai patients with chronic schizophrenia

• المؤلفون الرئيسيون: Suwanna Arunpongpaisal, Manit Srisurapanont, Ronnachai Kongsakon, Khanogwan Kitiwattanagul, Umpaikanit Samanwongthai
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77951895519&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/51104
• المؤسسة: Chiang Mai University

Background: Although oral atypical antipsychotics have improved the outcomes in schizophrenia, the patient medication adherence plays role as the important factor to clinical potential of the drugs. Therefore, the long-acting formulations of antipsychotics have been developed to improve the treatmen...